Detection of CBF beta/MYH11 fusion transcript: Value of minimal residual disease follow-up

被引：0
|
作者：
Costello, R
Cusenier, A
Sainty, D
Mozziconacci, MJ
Arnoulet, C
Blaise, D
Novakovitch, G
Maraninchi, D
Gastaut, JA
LafagePochitaloff, M
Gabert, J
机构：
[1] CTR CANC,DEPT BIOL,F-13009 MARSEILLE,FRANCE
[2] CTR CANC,DEPT CLIN HEMATOL,F-13009 MARSEILLE,FRANCE
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1996年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：825 / 825
页数：1
相关论文
共 50 条
  • [1] Value of reverse transcriptase-polymerase chain reaction follow-up of CBF beta/MYH11 fusion transcripts in acute myeloid leukemia
    Costello, R
    Sainty, D
    Gastaut, JA
    Gabert, J
    CANCER JOURNAL - FRANCE, 1997, 10 (05): : 262 - 265
  • [2] Detection and quantitation of the CBF beta/MYH11 transcripts associated with the inv(16) in presentation and follow-up samples from patients with AML
    Evans, PAS
    Short, MA
    Jack, AS
    Norfolk, DR
    Child, JA
    Shiach, CR
    Davies, F
    Tobal, K
    Yin, JAL
    Morgan, GJ
    LEUKEMIA, 1997, 11 (03) : 364 - 369
  • [3] Heterogeneity of CBF beta/MYH11 fusion transcripts in acute myeloid leukemia
    Costello, R
    Lecine, P
    Cusenier, A
    Sainty, D
    Mozziconacci, MJ
    Arnoulet, C
    Imbert, J
    Maraninchi, D
    Gastaut, JA
    LafagePochitaloff, M
    Gabert, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 826 - 826
  • [4] Detection and quantitation of MYH11/CBF beta transcripts in presentation and follow up samples from AML patients with INV(16).
    Evans, PAS
    Norfolk, DR
    Child, JA
    Shiach, CR
    Short, M
    Jack, A
    Tobal, K
    Yin, JAL
    Morgan, GJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 236 - 236
  • [5] Prospective monitoring of minimal residual disease by polymerase chain reaction in patients with acute myeloid leukemia expressing CBF beta/MYH11 fusion transcripts.
    Moos, M
    Schmohl, D
    Botz, D
    Fischer, K
    Schlenk, R
    Dohner, H
    BLOOD, 1997, 90 (10) : 3721 - 3721
  • [6] Detection and quantitation of the CBFβ/MYH11 transcripts associated with the inv(16) in presentation and follow-up samples from patients with AML
    PAS Evans
    MA Short
    AS Jack
    DR Norfolk
    JA Child
    CR Shiach
    F Davies
    K Tobal
    JA Liu Yin
    GJ Morgan
    Leukemia, 1997, 11 : 364 - 369
  • [7] Detection of CBF beta/MYH11 fusion transcripts in acute myeloid leukemia: Heterogeneity of cytological and molecular characteristics
    Costello, R
    Sainty, D
    Lecine, P
    Cusenier, A
    Mozziconacci, MJ
    Arnoulet, C
    Maraninchi, D
    Gastaut, JA
    LafagePochitaloff, M
    Gabert, J
    LEUKEMIA, 1997, 11 (05) : 644 - 650
  • [8] DETECTION OF THE CHROMOSOME-16 CBF-BETA-MYH11 FUSION TRANSCRIPT IN MYELOMONOCYTIC LEUKEMIAS
    POIREL, H
    RADFORDWEISS, I
    RACK, K
    TROUSSARD, X
    VEIL, A
    VALENSI, F
    PICARD, F
    GUESNU, M
    LEBOEUF, D
    MELLE, J
    DREYFUS, F
    FLANDRIN, G
    MACINTYRE, E
    BLOOD, 1995, 85 (05) : 1313 - 1322
  • [9] DETECTION OF THE CHROMOSOME-16 CBF-BETA-MYH11 FUSION TRANSCRIPT IN MYELOMONOCYTIC LEUKEMIAS
    POIREL, H
    RADFORDWEISS, I
    RACK, K
    TROUSSARD, X
    GUESNU, M
    VALENSI, F
    FLANDRIN, G
    MACINTYRE, E
    BLOOD, 1994, 84 (10) : A438 - A438
  • [10] PCR monitoring of minimal residual disease in acute myeloid leukemia expressing AML1/ETO or CBFb/MYH11 fusion transcript
    Melillo, LMA
    Saglio, G
    Minervini, MM
    Gottardi, E
    Serra, A
    Carotenuto, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 99 - 99
12345